Agios Presents Updated Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma
Agios and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Ivosidenib in Greater China
Sitka Drills 119.0 Metres of 1.01 g/t Gold from Surface, Including 10.7 Metres of 4.10 g/t Gold and 1.2 Metres of 24.8 g/t Gold, at the Contact Zone, Confirming Another near Surface Higher-Grade Gold Zone at Its RC Gold Project, Yukon
